Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1997 1
1998 1
1999 2
2000 5
2001 9
2002 8
2003 7
2004 5
2005 10
2006 15
2007 13
2008 14
2009 33
2010 35
2011 24
2012 36
2013 29
2014 26
2015 19
2016 14
2017 9
2018 10
2019 12
2020 20
2021 12
2022 15
2023 17
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Results by year

Filters applied: . Clear all
Page 1
Colesevelam.
[No authors listed] [No authors listed] 2022 Sep 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2022 Sep 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000454 Free Books & Documents. Review.
Colesevelam is a nonabsorbable resin. Because it does not enter the mother's bloodstream, it will not reach the infant via breastmilk. ...
Colesevelam is a nonabsorbable resin. Because it does not enter the mother's bloodstream, it will not reach the infant via breastmilk …
Colesevelam.
[No authors listed] [No authors listed] 2017 Sep 28. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Sep 28. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644180 Free Books & Documents. Review.
Colesevelam is a nonabsorbed bile acid sequestrant that is used a therapy of hyperlipidemia and for the pruritus of chronic liver disease and biliary obstruction. Colesevelam has not been associated with clinically apparent liver injury....
Colesevelam is a nonabsorbed bile acid sequestrant that is used a therapy of hyperlipidemia and for the pruritus of chronic liver dis …
Colesevelam in the management of type 2 diabetes.
Kalra S, Priya G, Aggarwal S. Kalra S, et al. J Pak Med Assoc. 2020 May;70(5):934-936. J Pak Med Assoc. 2020. PMID: 32400758 Review.
Colesevelam is a bile acid sequestrant, approved for the management of both dyslipidaemia and type 2 diabetes. This review discusses the potential for the use of colesevelam in the management of type 2 diabetes. Expert opinion suggests possible indications where …
Colesevelam is a bile acid sequestrant, approved for the management of both dyslipidaemia and type 2 diabetes. This review discusses …
Colesevelam.
Melian EB, Plosker GL. Melian EB, et al. Am J Cardiovasc Drugs. 2001;1(2):141-6; discussion 147-8. doi: 10.2165/00129784-200101020-00007. Am J Cardiovasc Drugs. 2001. PMID: 14728043 Review.
In animals colesevelam was not systemically absorbed after oral administration and was rapidly eliminated via the gastrointestinal tract. Colesevelam did not alter the serum concentrations or pharmacokinetic properties of drugs from several different classes in heal …
In animals colesevelam was not systemically absorbed after oral administration and was rapidly eliminated via the gastrointestinal tr …
Colesevelam.
Patel PH, Can AS. Patel PH, et al. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32491747 Free Books & Documents.
Colesevelam is an FDA-approved antihyperlipidemic drug. When treating hyperlipidemia, colesevelam should be used in conjunction with restriction of cholesterol and fat intake and exercise and can be used as a monotherapy or combined with an HMG-CoA reductase inhibit …
Colesevelam is an FDA-approved antihyperlipidemic drug. When treating hyperlipidemia, colesevelam should be used in conjunctio …
Colesevelam hydrochloride.
Steinmetz KL. Steinmetz KL. Am J Health Syst Pharm. 2002 May 15;59(10):932-9. doi: 10.1093/ajhp/59.10.932. Am J Health Syst Pharm. 2002. PMID: 12040732 Review.
The pharmacology, pharmacodynamics, clinical efficacy, drug interactions, adverse effects, and dosage and administration of colesevelam hydrochloride are reviewed. Colesevelam hydrochloride is a nonabsorbed lipid-lowering agent approved for use alone o …
The pharmacology, pharmacodynamics, clinical efficacy, drug interactions, adverse effects, and dosage and administration of colesevelam …
Colesevelam for type 2 diabetes mellitus.
Ooi CP, Loke SC. Ooi CP, et al. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD009361. doi: 10.1002/14651858.CD009361.pub2. Cochrane Database Syst Rev. 2012. PMID: 23235674 Free PMC article. Review.
BACKGROUND: Colesevelam is a second-generation bile acid sequestrant that has effects on both blood glucose and lipid levels. ...However, there is a limited number of studies with the different colesevelam/antidiabetic agent combinations. More information on the ben …
BACKGROUND: Colesevelam is a second-generation bile acid sequestrant that has effects on both blood glucose and lipid levels. ...Howe …
Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus.
Sonnett TE, Levien TL, Neumiller JJ, Gates BJ, Setter SM. Sonnett TE, et al. Clin Ther. 2009 Feb;31(2):245-59. doi: 10.1016/j.clinthera.2009.02.018. Clin Ther. 2009. PMID: 19302898 Review.
BACKGROUND: Colesevelam hydrochloride is a bile acid sequestrant approved in January 2008 by the US Food and Drug Administration (FDA) for the treatment of adult patients with type 2 diabetes mellitus (DM) in combination with a sulfonylurea, metformin, and/or insuli …
BACKGROUND: Colesevelam hydrochloride is a bile acid sequestrant approved in January 2008 by the US Food and Drug Administrati …
Anion-Exchange Electrospun Mixed-Matrix Polymer Fibers of Colesevelam for Water Treatment.
El-Mehalmey WA, Ibrahim AH, Youssef AFA, Abuzalat O, Mousa MS, Mayhoub AS, Alkordi MH. El-Mehalmey WA, et al. ACS Appl Mater Interfaces. 2023 Dec 18. doi: 10.1021/acsami.3c13473. Online ahead of print. ACS Appl Mater Interfaces. 2023. PMID: 38109475 Review.
Novel anion-exchange electrospun fiber membranes of polycaprolactone doped with the cationic, cross-linked colesevelam polymer are reported. The weight fraction of cross-linked cationic colesevelam polymer, as the active phase within the PCL matrix, can readily be c …
Novel anion-exchange electrospun fiber membranes of polycaprolactone doped with the cationic, cross-linked colesevelam polymer are re …
Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial.
Borup C, Vinter-Jensen L, Jørgensen SPG, Wildt S, Graff J, Gregersen T, Zaremba A, Borup Andersen T, Nøjgaard C, Timm HB, Rainteau D, Hansen SH, Rumessen JJ, Munck LK. Borup C, et al. Lancet Gastroenterol Hepatol. 2023 Apr;8(4):321-331. doi: 10.1016/S2468-1253(22)00401-0. Epub 2023 Feb 6. Lancet Gastroenterol Hepatol. 2023. PMID: 36758570 Clinical Trial.
Low-certainty evidence supports sequestrant treatment, including colesevelam. We aimed to determine the efficacy and safety of colesevelam in bile acid diarrhoea. ...FINDINGS: Between Oct 25, 2018, and July 1, 2021, 168 patients were randomly assigned to receive …
Low-certainty evidence supports sequestrant treatment, including colesevelam. We aimed to determine the efficacy and safety of col …
354 results